| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,631 |
14,857 |
$3.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,817 |
4,784 |
$1.31M |
| 80053 |
Comprehensive metabolic panel |
6,229 |
4,932 |
$129K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
654 |
629 |
$75K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
356 |
261 |
$57K |
| 85027 |
|
7,245 |
5,710 |
$48K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,626 |
2,079 |
$38K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,539 |
1,333 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,150 |
2,610 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,014 |
1,511 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,248 |
1,167 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
1,219 |
968 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
319 |
300 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
269 |
257 |
$8K |
| 83690 |
|
1,028 |
827 |
$7K |
| 81025 |
|
459 |
433 |
$6K |
| 81003 |
|
854 |
719 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
93 |
66 |
$6K |
| 87430 |
|
228 |
225 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,762 |
1,312 |
$5K |
| 81001 |
|
582 |
495 |
$4K |
| 84484 |
|
383 |
278 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
272 |
223 |
$3K |
| 87070 |
|
109 |
109 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$2K |
| 85378 |
|
73 |
60 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
474 |
438 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
242 |
226 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
357 |
325 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
146 |
141 |
$488.86 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
28 |
27 |
$279.65 |
| 85730 |
|
98 |
64 |
$247.21 |
| 85610 |
|
136 |
88 |
$238.89 |
| 87807 |
|
13 |
13 |
$154.66 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
63 |
42 |
$0.00 |